A detailed history of Allstate Investment Management CO transactions in Seagen Inc. stock. As of the latest transaction made, Allstate Investment Management CO holds 6,207 shares of SGEN stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,207
Holding current value
$0
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$117.37 - $139.17 $728,515 - $863,828
6,207 New
6,207 $0

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Allstate Investment Management CO Portfolio

Follow Allstate Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Investment Management CO with notifications on news.